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background:  The outcomes of use of hemodynamic support during high risk percutaneous coronary interventions (PCI) in the very elderly is 
unknown.
Methods:  Patients undergoing high risk PCI with unprotected left main or last patent conduit and left ventricular ejection fraction (LVEF) ≤30% 
were enrolled in PROTECT II at 112 sites and randomized to intra-aortic balloon pump (IABP) and Impella 2.5. All eligible patients that met study 
eligibility criteria were included in this analysis (N=427) and outcomes were compared between octogenarians (N=59) and non-octogenarians 
(N=368).
results:  At 90 days, the Major Adverse Event (MAE) and Major Cardiac and Cerebral Events (MACCE) rates were similar between octogenarians and 
non-octogenarians (45.6% vs. 44.1%, p=0.8) and (23.7% vs.26.8%, p=0.6) respectively. There were no differences in death, stroke or myocardial 
infarction rates between octogenarians and non-octogenarians (8.5% vs. 10.7%, p=0.6; 3.4% vs. 1.6%, p=0.6; 13.6% vs. 10.4%, p=0.5) respectively. 
Multivariate analysis confirmed that age ≥80 was not an independent predictor for occurrence of MAE or MACCE at 90 days, while the use of Impella 
2.5 was a predictor for MAE free survival at 90 days independent of age (Table 1).
conclusions:  The use of percutaneous support is reasonable in the octogenarian population with similar outcomes when compared with a group 
of younger patients. When compared to IABP, the Impella 2.5 appeared to be an independent predictor of improved outcomes independent of age.
Table 1: Logistic Model for 90-day MAE Outcomes
Variable Estimate
Standard 
Error
Pr>
Chi-Square
Odds Ratio 
Estimate
Lower 95% Confidence 
Limit for Odds Ratio
Upper 95% Confidence 
Limit for Odds Ratio
Device: IMPELLA -0.2013 0.1015 0.0473 0.669 0.449 0.995
Age>=80 -0.1706 0.1542 0.2685 0.711 0.388 1.301
Diabetes Mellitus 0.1441 0.2089 0.5851 1.121 0.744 1.688
Reason for Initial Admission: 
Acute MI
0.3150 0.3273 0.3359 1.370 0.721 2.602
Renal Insufficiency 0.6166 0.2477 0.0128 1.853 1.140 3.011
Hgb (g/dl) -0.1024 0.0590 0.0825 0.903 0.804 1.013
Prior PCI -0.0860 0.2073 0.6781 0.918 0.611 1.378
